Health Care/Hospital News & Press Release Distribution

Harbour BioMed Announces Dosing of First Patients in Two Phase II Clinical Studies of Batoclimab (HBM9161) for the Treatment of Myasthenia Gravis and Immune Thrombocytopenia

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Sept. 30, 2020 /PRNewswire/ -- Harbour BioMed (HBM), a global, clinical-stage, bio-pharmaceutical company announced today the dosing of the first patient in two separate Phase II clinical trials of Batoclimab (HBM 9161), a fully human...

2020-09-30 21:50 5131

OriCiro Launches World's First Cell-Free Amplification Technology for Large Circular DNA

TOKYO, Sept. 30, 2020 /PRNewswire/ -- OriCiro Genomics, a pioneer in the cell-free synthesis and amplification of genome-scale large DNA for gene therapy and synthetic biology, has today launched the OriCiroTM Cell-Free Cloning System, the world's first technology enabling cell-free amplification...

2020-09-30 21:47 3030

Independent multi-center trial shows that Getinge's NAVA ventilation mode shortens time of mechanical ventilation by almost 35% for adult ICU patients

GOTHENBURG, Sweden, Sept. 30, 2020 /PRNewswire/ -- The clinical effectiveness of Getinge's patented Neurally Adjusted Ventilatory Assist (NAVA), which uses the patient's own respiratory drive to control ventilator assistance, is supported in the NAVIATOR trial. According to the NAVIATOR trial, N...

2020-09-30 21:45 13961

Firmenich Opens New Era in Ingredient Creation with Launch of Biotech and Naturals Pilot Plant in Geneva

GENEVA, Switzerland, Sept. 30, 2020 /PRNewswire/ -- Firmenich, the world's largest privately-owned Perfume and Taste company, is proud to announce the opening of its new biotechnology and naturals pilot plant and laboratory in Geneva. Benefiting from the latest digital technology, the facility ope...

2020-09-30 21:36 3423

MARii and Sengenics Launch ImmuSAFE® - World's First Multi-Antigen, Epitope Specific, Fully Quantitative COVID-19 Test

CYBERJAYA, Malaysia, Sept. 30, 2020 /PRNewswire/ -- The Malaysia Automotive, Robotics and IoT Institute (MARii) and Sengenics Sdn. Bhd. launched the ImmuSAFE COVID+ biochip, at MARii's headquarters, Cyberjaya. From left: Dr. Faizal Anwar, MAR...

2020-09-30 20:21 5700

MARii and Sengenics Launch ImmuSAFE® - World's First Multi-Antigen, Epitope Specific, Fully Quantitative COVID-19 Test

I-Mab Receives China CDE Approval to Initiate Phase 3 Clinical Trial of Eftansomatropin in Pediatric Patients with Growth Hormone Deficiency

SHANGHAI and GAITHERSBURG, Md., Sept. 30, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the China Center for Drug Evaluation (CDE) has app...

2020-09-30 20:00 11593

The 11th China (Taizhou) International Medical Expo ended successfully

NANJING, China, Sept. 30, 2020 /PRNewswire/ -- From September 19 to 21, the 11th China (Taizhou) International Medical Expo was held at the China Medical City Exhibition Center. With the theme of "Development Trends in the Medical and Health Industry under the Epidemic", the current medical expo h...

2020-09-30 19:52 1483

The 11th China (Taizhou) International Medical Expo ended successfully

111, Inc. Builds Digitally-enabled, Omni-channel Drug Commercialization Platform as Part of its Goal to Provide Full Life-cycle Healthcare Management Solutions for Patients

SHANGHAI, Sept. 30, 2020 /PRNewswire/ -- On September 24, 2020, 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading digital healthcare platform dedicating to digitally connecting patients with drugs and healthcare services inChina, hosted its 3rd annual China Online Healthcare Summit and P...

2020-09-30 18:00 22026

TaiGen Biotechnology Out-Licensed Taigexyn (Nemonoxacin) to Luminarie Canada for Canada, Australia and New Zealand

TAIPEI, Sept. 30, 2020 /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen")(Taiwan: 4157) today announced that they have signed an exclusive licensing agreement with Luminarie Canada Inc. ("Luminarie"), a leading Canadian pharmaceutical company, to develop and commercialize Taigexyn® ...

2020-09-30 15:51 1616

Lipidor announces positive outcome of feasibility study for development of topical medical cannabis products based on the company's AKVANO® technology

STOCKHOLM, Sept. 30, 2020 /PRNewswire/ -- Lipidor AB (Nasdaq First North:LIPI) today announces a positive outcome of the feasibility study into the development of topical medicinal cannabis products for the treatment of skin inflammations and psoriatic lesions. The study was conducted in collabor...

2020-09-30 15:44 2891

HeyGears Announces its Latest Innovations in Digital Manufacturing Solutions: A Clear Aligner Production Solution and UltraCraft A2D 4K

GUANGZHOU, China, Sept. 30, 2020 /PRNewswire/ -- At Dental South China International Expo, HeyGears announces two of its latest innovations in digital manufacturing solutions. First, HeyGears' clear aligner production solution that allows 24/7 mass production of clear aligner models and digitally...

2020-09-30 13:17 2759

HeyGears Announces its Latest Innovations in Digital Manufacturing Solutions: A Clear Aligner Production Solution and UltraCraft A2D 4K

Statement from Bill & Melinda Gates Foundation CEO Mark Suzman on Momentum in Global COVID-19 Response

SEATTLE, Sept. 30, 2020 /PRNewswire/ -- The death toll from COVID-19 passed one million this week. It is a sobering moment. But there is cause for optimism as recent days have seen a significant surge in momentum around global cooperation, which is our greatest strength when it comes to consignin...

2020-09-30 12:01 2239

BioGX launches CE-IVD Marked COVID-19, Influenza A/B, RSV Combo RT-PCR Test for the BD MAX™ System

AMSTERDAM, Sept. 30, 2020 /PRNewswire/ -- BioGX BV, the European subsidiary of Birmingham, Alabama based BioGX, announced availability of a CE-IVD marked test for simultaneous detection of SARS-CoV-2, Influenza A, Influenza B and Respiratory Syncytial Virus RNA in a patient sample using the BD MA...

2020-09-30 06:06 2603

The Copperline Mask: The First Face Mask in Asia Independently Verified to Kill SARS-CoV-2

SINGAPORE, Sept. 30, 2020 /PRNewswire/ -- Today, Yappie Pte. Ltd. ("Yappie") announced that Korea's Copperline Mask has been independently verified to be the first face mask inAsia to kill SARS-CoV-2. The Copperline Mask's patented ionised copper yarn knitted fabric actively eliminates bacteria ...

2020-09-30 03:56 3555

JIECANG announced the official opening of the new headquarters at the 20th anniversary celebration

SHAOXING, China, Sept. 29, 2020 /PRNewswire/ -- On September 28, JIECANG celebrated its 20th anniversary in JIECANG Life and Health Industrial Park in Zhejiang. With its customer-centric strategy, strong product customization capabilities and production capacity, two decades of focus in linear mot...

2020-09-29 23:22 10979

JIECANG announced the official opening of the new headquarters at the 20th anniversary celebration

Data Science to Accelerate Drug Discovery with Artificial Intelligence and Machine Learning, Says Frost & Sullivan

Pharmaceutical companies and hospitals are adopting data science rapidly, and its application is going to be established in all branches of healthcare SANTA CLARA, Calif., Sept. 29, 2020 /PRNewswire/ -- Frost & Sullivan's recent analysis,Data Science Impacting the Pharmaceutical Industry, finds t...

2020-09-29 22:10 2922

Data Science to Accelerate Drug Discovery with Artificial Intelligence and Machine Learning, Says Frost & Sullivan

Picarro Expands Presence in Asia with New Customer Service and Support Office in South Korea

SANTA CLARA, California, Sept. 29, 2020 /PRNewswire/ -- Picarro Inc., a leading provider of trace gas analyzers for a variety of air monitoring applications, is expanding its presence inAsia by opening a customer service and support office in Hwaseong,South Korea. Having sales staff, repair ser...

2020-09-29 21:48 2693

BrightInsight Named 2020 Global Entrepreneurial Company of the Year by Frost & Sullivan for Advancing Digital Health Innovation in Biopharma and Medtech

BrightInsight adds more value to its biopharma and medtech customers' digital health products through its modern and customizable platform architecture, pre-built software assets, and managed service SANTA CLARA, Calif., Sept. 29, 2020 /PRNewswire/ -- Based on its recent analysis of the global h...

2020-09-29 21:18 2454

BrightInsight Named 2020 Global Entrepreneurial Company of the Year by Frost & Sullivan for Advancing Digital Health Innovation in Biopharma and Medtech

BrightInsight adds more value to its biopharma and medtech customers' digital health products through its modern and customizable platform architecture, pre-built software assets, and managed service SANTA CLARA, Calif., Sept. 29, 2020 /PRNewswire/ -- Based on its recent analysis of the global h...

2020-09-29 21:00 2523

Ajinomoto Bio-Pharma Services and DNDi Partner to Develop Critical Immunomodulator for Cutaneous Leishmaniasis Therapeutic

OSAKA, Japan, Sept. 29, 2020 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce a strategic supply partnership with the Drugs for Neglected Disease Initiative (DNDi), a ...

2020-09-29 20:01 2534